ArticleBMC gastroenterology2022

Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study).

Yohei Iimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.